isoxazoles has been researched along with Urinary Bladder Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, Y; Ma, W; Mao, S; Wang, R; Wu, Y; Yan, Y; Yao, X; Yuan, J; Zhang, J; Zhang, W | 1 |
| Abe, K; Arnold, LL; Cohen, SM; Kakiuchi-Kiyota, S; Kyoya, T; Pennington, KL; Terada, M | 1 |
| Cui, Y; Dreicer, R; Emamekhoo, H; Frankel, PH; Hoimes, C; Kim, WY; Lara, PN; Lyou, Y; Michaelson, D; Milowsky, M; Mortazavi, A; Newman, E; Pal, SK; Parikh, M; Parikh, R; Srinivas, S; Teply, B; Vaishampayan, U; Weng, P; Zhang, T | 1 |
| Agarwal, PK; Hammerich, KH; Hao, JJ; Krane, LS; Li, QQ; Neckers, L; Sanford, T; Trepel, JB; Zhang, Z | 1 |
| Chekaluk, Y; Du, J; Gray, NS; Guo, Y; Kwiatkowski, DJ; Wu, CL; Zhang, J | 1 |
| Abanobi, SE; Laconi, E; Rajalakshmi, S; Rao, PM; Sarma, DS; Vasudevan, S | 1 |
1 trial(s) available for isoxazoles and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Isoxazoles; Male; Pyrazines; Treatment Outcome; Urinary Bladder Neoplasms | 2021 |
5 other study(ies) available for isoxazoles and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Intraoperative use of single dose of nonsteroidal anti-inflammatory drugs was not associated with cancer recurrence and mortality after bladder cancer surgery: a retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Disease-Free Survival; Humans; Intraoperative Care; Isoxazoles; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Retrospective Studies; Urinary Bladder Neoplasms | 2020 |
Urinary crystal formation and urothelial effects of pyroxasulfone administered to male rats.
Topics: Animals; Carcinogenicity Tests; Cell Proliferation; Crystallization; Dose-Response Relationship, Drug; Herbicides; Hyperplasia; Isoxazoles; Male; Necrosis; Rats, Sprague-Dawley; Risk Assessment; Sulfones; Time Factors; Urinary Bladder Neoplasms; Urinary Calculi; Urothelium | 2020 |
Proteomic analysis of proteome and histone post-translational modifications in heat shock protein 90 inhibition-mediated bladder cancer therapeutics.
Topics: Antineoplastic Agents; Benzamides; Benzodioxoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 4 or More Rings; Histones; HSP90 Heat-Shock Proteins; Humans; Imidazoles; Isoindoles; Isoxazoles; Protein Processing, Post-Translational; Proteomics; Resorcinols; Triazoles; Urinary Bladder Neoplasms | 2017 |
TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.
Topics: Afatinib; Antibiotics, Antineoplastic; Cell Line, Tumor; ErbB Receptors; HSP90 Heat-Shock Proteins; Humans; Isoxazoles; Lapatinib; Loss of Heterozygosity; Naphthyridines; Phosphorylation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Quinazolines; Resorcinols; Signal Transduction; Sirolimus; Tuberous Sclerosis Complex 1 Protein; Tuberous Sclerosis Complex 2 Protein; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 2013 |
Effect of glycine on the induction of orotic aciduria and urinary bladder tumorigenesis in the rat.
Topics: Ammonium Chloride; Animals; Aspartic Acid; Cycloheximide; Glycine; Isoxazoles; Male; Orotic Acid; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms | 1987 |